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Summary 
 
The rising costs of health care, the outbreak of drug resistant organisms, health 
depleting lifestyles and the risky side effects of currently used drugs are world-wide 
problems. This has led to the search for novel drugs and drug leads. Traditional 
healers and other individuals across the globe possess unlimited knowledge on the 
healing powers of different plants that has been passed on through generations. This 
knowledge together with scientific investigations can lead to the eradication of most 
of the diseases either by treatment or prevention. 
 
Aloe ferox Mill. is one of the plants that have gained a lot of interest from the 
pharmaceutical industry. The plant has over 80 documented medicinal uses. These 
include treatment of impotence and infertility, sexually transmitted infections, arthritis, 
hypertension, leukaemia, bacterial and fungal infections. It is also known as a blood 
purifier, widely used as a laxative and anti- inflammatory agent. More research is 
required to discover more about A. ferox and its benefits to health as well as to 
investigate its potential for the development of novel drugs.  
 
The current study was focused at investigating the anti- cancer, anti- microbial anti- 
diabetic, cytotoxic activities and phytochemical composition of leaf extracts of A. 
ferox. Three cancer cell lines namely: breast (MCF7), colon (HCT116) and prostate 
(PC3) cancer cell lines were used to investigate the anticancer activity of the extracts 
using the Sulforhodamine B (SRB) method. 
 
To determine the anti- diabetic activity of the plant extracts the C2C12 and Chang 
cell in- vitro models of glucose uptake were used. The micro- dilution technique was 
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used to evaluate the antibacterial and antifungal activity of the extract. The safety of 
these extracts against normal human foetal lung fibroblasts (W138), Chang and 
C2C12 cells was done by through the SRB and the MTT methods. To determine the 
phytochemical profile of A. ferox the DPPH radical scavenging and the Folin 
Ciocalteu methods were used to test the antioxidant activity and the total phenolic 
content of the different extracts respectively. Different methods were used to 
determine the presence of phytochemicals such as steroids, saponins, alkaloids, 
carbohydrates and flavonoids. LCMS was also done to detect the elemental 
composition of the plant extracts. 
 
According to the CSIR criteria A. ferox was inactive against the cancer cell lines 
used. It however exhibited antioxidant activity even at low concentrations, with an 
EC50 of 0.865 ± 0.783. The methanol extract showed more phenolic content than 
the dichloromethane and aqueous extracts at a concentration of 5mg/ml. It is 
believed that the antioxidant activity correlates with the phenolic content and quality 
of the phenols present in the plant and more assays have to be done to prove this 
hypothesis. Other phytochemicals found in the extract included saponins, steroids, 
alkaloids as well as flavonoids. Both the methanol and aqueous extracts of A. ferox 
caused a significant increase in glucose uptake by C2C12 cells but caused a slightly 
decreased uptake by the Chang cells. The plant extracts inhibited the growth of 
Staphylococcus epidermidis, Streptococcus pneumonia, Escherichia coli and 
Candida albicans at a concentration of 15mg/ml extract. Candida tropicalis and 
Escherichia faecalis were resistant to A. ferox extracts. Finally the extracts showed 
no toxic activity against the normal foetal lung fibroblasts, Chang and C2C12 cells 
validating the safety of this plant for human use. 
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The results in conjunction with literature findings show A. ferox to be a promising 
source of drugs and therapeutic agents. Due to the fact that traditional healers 
already rely on it as treatment for different ailments, it is important that the safety of 
the plant for use has been validated though other studies and clinical trial still need 
to be done to fully confirm this. All the information gathered also showed this plant to 
be of great benefit against major health problems, responsible for millions of deaths 
each year such as cancer, cardiovascular and inflammatory diseases, and diabetes.  
There is however still a great need for more investigation to be done on this plant 
against a vast majority of organisms and diseases so as to fully benefit from it. 
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CHAPTER 1 
 
Background 
 
The need for less expensive health care has led to an increased search for and use 
of medicinal plants. Different plant parts, such as leaves, bark, flowers, fruit, stems 
and roots, or the whole plant can be used to obtain active compounds for therapeutic 
use. Plants serve not only as novel sources of drugs, but also as drug leads for 
optimisation by medicinal and synthetic chemists (Balunas and Kinghorn, 2005). The 
therapeutic activity of plants has been explained as a result of the synergistic effects 
of phytochemicals in the different plants. Drug discovery from plants has evolved 
from the use of crude preparations to the isolation and identification of active 
compounds (Balunas and Kinghorn, 2005). Predetermined and novel molecular 
targets in diseases can be targeted through the identification and isolation of some 
compounds from particular plants, giving them the ability to have selective activity in 
eradicating the disease (Kramer and Cohen, 2004; Balunas and Kinghorn, 2005). 
Examples include indirubin, which selectively inhibits cyclin-dependent kinases 
(Hoessel et al., 1999; Eisenbrand et al., 2004) and β-lapachone, selectively targeting 
cancer cells over normal cells through checkpoint activation during the cell cycle (Li 
et al., 2003; Balunas and Kinghorn, 2005).  
 
Some of the earliest drugs isolated from plants include digitoxin, codeine, cocaine, 
quinine and morphine, of which some are still in use (Newman et al., 2000; Butler, 
2004; Samuelsson, 2004). Between 1981 and 2002 around 48% of all new chemical 
entities were obtained from natural products or their derivatives (Butler, 2004). Table 
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1.1 shows some of the newly identified, validated and approved plant-derived drugs 
that were introduced to the market. 
 
The significant role of plants in drug discovery is most evident in the areas of cancer 
and infectious inflammatory diseases, where respectively 60% and 75% of the drugs 
used are of natural origin (Newman et al., 2003). These diseases are some of the 
main causes of mortality worldwide. However, other diseases, such as tuberculosis 
and diabetes, are also rapidly becoming part of the main causes of premature deaths 
worldwide, with a person dying every few seconds from these diseases or from the 
resulting complications. 
 
Extensive research has shown a negative correlation between the consumption of a 
diet rich in fruit and vegetables and the risk of chronic diseases such as arthritis, 
cardiovascular diseases, chronic inflammation and cancer (Zhang et al., 2005). 
Plant-based sources of medication are a highly promising and untapped source of 
pharmaceutical drugs that are effective in the prevention and treatment of diseases 
in view of their abundant phenolic content, among other beneficial secondary 
compounds (Conforti et al., 2008). A great deal of progress has been made in areas 
of research to find effective and therapeutically valuable compounds from plants. 
However there is still a lot to be done to find and identify more plants with 
compounds or a combination thereof with fewer or no side effects on normal cells or 
physiological activities. 
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Table 1.1. Plant-derived drugs recently introduced to the market. 
Drug name Trade name Plant name (Source) Use References 
Arteether Artemotil Artemisia annua L. Anti-malarial drug Van Agtmael et al., 1999; Graul, 2001. 
Galantamine Reminyl Galanthus woronowii L. Treatment of 
Alzheimer’s disease 
Heinrich and Teoh, 2004; Pirttila et al., 
2004. 
Nitisinone Orfadin Callistemon citrinus 
Stapf. 
Tyrosinaemia Hall et al., 200lb; Mitchell et al., 2001. 
Tiotropium Spiriva Atropa belladonna L. 
and other members of 
the Solanaceae family 
Chronic obstructive 
pulmonary disease  
Mundy and Kirkpatrick, 2004; Frantz, 
2005. 
(Balunas and Kinghorn, 2005) 
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Traditional medicine is the pivot of most of the current search for drugs and drug 
leads worldwide. There is no tribe or country that does not depend on plants and 
herbs for some form of therapy. Semenya et al. (2012) stated that about 80 - 85% of 
black South Africans in both urban and rural areas use traditional medicine from 
local healers and herbalists. Most of these plants are sold in local markets, but not all 
of them have been scientifically proven to work. Validating the use of these plants in 
the health care system requires scientific investigations on their effects, safety, 
quality as well as appropriate dosages (Masika and Afolayan, 2002). Only 10% of 
the higher plant species have been studied chemically and pharmacologically.  
 
1.1. Literature review 
Oxidative stress results from the overproduction of reactive oxygen species (ROS) 
and reactive nitrogen species (RNS), which are products of normal cellular 
metabolism (Valko et al., 2006). At high concentrations they are harmful and function 
by mediating the destruction of the cell structure, cellular lipids and proteins, as well 
as cell membrane and deoxyribonucleic acid (DNA).These species are the key 
players in the development of diseases, especially tumoural and inflammatory 
diseases such as cancer, atherosclerosis, tuberculosis, diabetes, cardiovascular and 
neurodegenerative disorders.  
 
Antioxidant defences are just one of the mechanisms developed by organisms to 
protect themselves against free radicals (Cadenas, 1997; Valko et al., 2007). There 
are different types of antioxidants and different mechanisms through which they 
function. The following is a list of some of the different mechanisms of action: 
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1. Degradation of free radicals by enzymes such as superoxide dismutase, 
ascorbate peroxidase and catalase (Mittler, 2002). 
2. Metals enhancing free radical production by proteins such as transferrin, 
antioxidants binding to these metals, preventing free radical production. 
3. Free radical scavenging by antioxidants such as vitamin C and E, as well as 
glutathione (Pencofer et al., 2002). 
The plant antioxidants studied most frequently are polyphenols, which are abundant 
in plants, hence those with the strongest antioxidant activity and total phenolic 
content are the most valuable (Larkins and Wynn, 2004). Some plant antioxidants 
include cinnamic acids, counarins, diterpenes, flavonoids, lignans, monoterpenes, 
phenylpropanoids, tannins and triterpenes (Larkins and Wynn, 2004). 
 
Flavonoids are the most common group of plant phenols mainly acting as 
antioxidants that are involved in free radical scavenging (Urquiaga and Leighton, 
2000). They can combat cancer by inhibiting initiation, promotion and progression of 
tumours. Polyphenols function through a number of biological effects such as 
protecting DNA from oxidative damage, hence inhibiting late age development of 
cancers and diabetes. In addition to the action of flavonoids, phenolic acids and 
hydrolysable tannins have anti-carcinogenic and antimutagenic effects (Urquiaga 
and Leighton, 2000). It is therefore highly advisable for individuals to indulge in a diet 
rich in fruit and vegetables, which can go a long way in preventing and delaying the 
onset of chronic diseases.   
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Cancer results from a disturbance within the cell cycle causing uncontrolled cell 
proliferation (Ruffa et al., 2002). The disease is caused by alterations in oncogenes, 
tumour suppressor genes as well as messenger ribonucleic acid  genes (Carlo and 
Crose, 2008). These are molecular factors involved in the development and inhibition 
of cancer. The most frequently studied ones include p53, p21 and Bcl-2; p53 is a 
tumour-suppressor gene responsible for apoptosis, p21 a cell cycle regulator 
responsible when activated for causing arrest in the G1 phase of the cell cycle and 
Bcl-2 is an anti-apoptotic factor (Kuo et al., 2002). All the factors are involved in the 
regulation of the cell cycle; especially those that induce apoptosis are usually the 
main focus when investigating anti-cancer therapy (Fisher, 1994; Brown and 
Woulters, 1999). 
 
 In 2002 there were an estimated 10.9 million new cancer cases, 6.7 million cancer-
related deaths and 24.6 million people living with cancer within five years of 
diagnosis world-wide (Parkin et al., 2002). These numbers were a significant 
increase from the estimates made in 2000 of 22 million people living with cancer and 
6 million deaths (Parkin et al., 2001). According to the statistics, lung cancer is the 
most common, followed by breast, stomach, liver, colon and rectal cancers 
respectively.  
 
There is a correlation between the intake of non-steroidal anti-inflammatory drugs 
and the reduced incidence of certain cancers, including colon, rectum and stomach 
cancer (Langman et al., 2000).  This is because a link has been established between 
cancer and inflammation (Balkwill and Mantovani, 2001). The inflammatory 
environment allows for easy proliferation, survival and metastasis of tumours through 
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the selectins, chemokines and receptors. ROS and RNS such as hydroxyl (OH), 
peroxyl (RO2) and nitric oxide radical (NO) are observed in chronic inflammatory 
diseases such as rheumatoid arthritis and hepatitis, as well as in cancers and 
diabetes (Sabu and Kuttan, 2002). These entities have been experimentally shown 
to be mutagenic and carcinogenic and they play a key role in the development of 
inflammatory diseases and their progression to cancer (Wiseman and Halliwell, 
1996). Their release leads to tissue damage and the release of cytokines such as 
interleukin-1 and 6, tumour necrosis factor and interferon-y (Conforti et al., 2008). 
Tumour-associated macrophages, tumour-infiltrating lymphocytes that produce pro-
inflammatory cytokines, growth factors, chemokines, signal transducers and 
transcriptional activators are found on the inflammatory site of tumours. The above-
mentioned substances promote growth and invasion by mechanisms such as 
inhibition of apoptosis, and DNA repair mechanisms (Neergheen et al., 2010). The 
relation between cancer and inflammation permits for the use of anti-inflammatory 
drugs in the prevention of and inhibition of the progression of cancer.  
 
The current methods for cancer treatment include radiation, chemotherapy and 
surgery or a combination of two or all of them. There are currently several plant-
derived agents that are in clinical use for cancer treatment. These include 
vinblastine, vicristine and camptothecin derivatives, topotecan, etoposide derived 
from epipodophyllotoxin and paclitaxed (Cragg and Newman, 2005). However, these 
treatments are not ideal in view of their toxicity and low survival rates. They have 
several more side effects that are sometimes just as harmful as the cancer itself, 
such as leukaemia and anaemia, they also destroy normal cells (McWhirter and 
Pennington, 1996). The search for selective anti-cancer drugs from plant sources 
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may lead to the discovery of new drugs that are less toxic and target cell division 
components, making them selective in their action (Mashele and Kolesnikova, 2010). 
 
Current anti-cancer drugs function by inhibiting the enzymatic activity of certain 
oncogenes. They also target specific junctions within the cell cycle. Natural 
phytochemicals have a range of activities ranging from inhibition of genotoxic effects, 
increased antioxidant and anti-inflammatory activity, inhibition of proteases and cell 
proliferation to protection of apoptosis and signal transduction pathways (Neergheen 
et al., 2010).  
 
The variety of  signs and symptoms which are often unclear that results from cancer 
make it difficult to find specific antitumor agents  (Steenkamp and Gouws, 2006), It is 
for that reason and the fact that  cancer has only recently been considered a 
common problem that make it rare to get reports of specific anti- cancer agents. 
Plants and their derivatives that can be used to treat or prevent inflammatory 
diseases, bacterial, viral and parasitic infections are of great interest in the 
pharmaceutical industry, as the above-mentioned diseases cause a disease state 
similar to that of cancer (Cordell et al., 1991). Plants and their derivatives have 
played an important role in the development of numerous clinically useful anti-cancer 
agents.  
 
Table 1.2 shows examples of plants that display high antioxidant activity, making 
them potential anti-cancer agents. Their anti-cancer activity and potential as chemo-
preventative agents are explained as a result of the detoxifying enzymes and 
antioxidant enzymes (Neergheen et al., 2010). However, the activity may also be 
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due to the inhibition of the cyclooxygenase activity of COX-2, eg by Platycodon 
grandiflorum (Ahn et al., 2005; Neergheen et al., 2010) and therefore, the reduction 
of prostaglandin production.  
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Table 1.2. Potential plant sources of anti-cancer agents. 
Family Plant species Antioxidant activity 
Asteraceae Bacharis grisebachii Scavenger of superoxide radicals. 
Campanulaceae Platycodon grandiflorum Inhibition of lipid peroxidation and a scavenger of DPPH. 
Ebenaceae Diospsyros mellanida 
Diospsyros revaughanii 
Diospsyros neraudii 
Hyprochlorous acid. Hydroxyl and peroxyl free radical scavenging activity.  
Fabaceae Bauhinia racemosa 
Acacia salicina 
Reduced lipid peroxidation and upregulation of the antioxidant levels. 
Scavenger of DPPH and inhibitor of superoxide radical production 
respectively. 
Lamiaceae Rosmarinus officinalis Substantial trolox equivalent activity. 
Myrtaceae Syzygium commersonii 
Syzygium glomeratum 
Eugenia pollicina 
Hypochlorous acid, hydroxyl radical and peroxyl radical scavenger 
Source: (Neergheen et al., 2010) 
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Diabetes is an endocrine disorder characterised by hyperglycaemia caused by 
complete or relative insulin deficiency (Narkhede et al., 2011). By 2007 there were 
3.5 million diabetes-related deaths worldwide, most of which resulted from 
cardiovascular complications (Das and Rai, 2008). By 2011 an estimated 25% of the 
world population was affected by this disease (Kavishanka et al., 2011). Other 
complications, such as glucose intolerance and hyperglycaemia, might manifest in 
cellular damage, renal and retinal, as well as neurological diseases (McCue et al., 
2005). Previously termed “rich people’s disease”, as it was prevalent in developed 
societies, diabetes has since spread to other societies owing to changing lifestyles 
(Narkhede et al., 2011).  
 
There are many different types of this disease; however, types 1 and 2 are most 
prevalent. Type 1 diabetes is autoimmune, characterised by destruction of the 
insulin-secreting beta cells of the pancreas, leading to insulin deficiency. Type 2 is 
characterised by insulin resistance or abnormal secretion of insulin (Shafrir, 1996; 
Semenya et al., 2012). Oxidative stress is seen in both types of diabetes (Nazirogilu 
et al., 2005) and leads to pathogenesis and resulting complications (Rahimi et al., 
2005; Shih et al., 2002). Oxidative stress is due to increased glucose oxidation, 
leading to the formation of free radicals, a decrease in enzymes that remove the free 
radicals and the increased binding of advanced glycation end products (AGEs) to the 
AGE receptors. The binding to receptors can lead to the modification of cell 
signalling, leading to further free radical production causing more complications 
(Pencofer et al., 2002). Diabetes places affected individuals at high risk of 
contracting other diseases such as tuberculosis (TB); according to the World Health 
Organization (WHO) about 10% of all TB cases are linked to diabetes (WHO, 2011). 
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Phenolic- rich Chinese and Indian plants have long been used to treat diabetes 
(Grover et al., 2002). In addition, more plants that have anti-diabetic properties are 
being discovered, eg Caesalpinia digyna and other members of the Caesalpinia 
genus, such as C. sappan and C. bonducella. 
 
Diabetes mellitus 2 can be managed through reduction of the postprandial blood 
glucose level by targeting and reducing the enzymes involved in carbohydrate 
metabolism alpha amylase and alpha glucosidase (Narkhede et al., 2011).  
Phytochemicals in medicinal plants are thought to function among other mechanisms 
through regeneration of the pancreatic beta cells leading to insulin release 
(Kavishankar et al., 2011). The Asphodelaceae family has lately generated a lot of 
interest in the pharmaceutical industry because of its rich phytochemical content and 
its local traditional use for ailments such as diabetes, hypertension, cancer, sexually 
transmitted diseases and wound healing, among others. 
 
Aloe L. is a big genus comprising over 500 species (Frodin, 2004; Grace, 2011), with 
about 60 species of aloes documented in traditional medicinal use in Southern Africa 
(Grace et al., 2008; Grace et al., 2011). The most recorded species in use are A. 
ferox, A. marculata, A. marlothii, A. micrantha, A. tenuior and most of all A. vera 
(Williams et al., 2001). Two materials obtained from aloe leaves seem to be the 
basis of all aloe-derived products thus far. These are the leaf exudates, mostly used 
for their laxative properties, and the leaf mesophyll, used for general, skin and 
digestive problems (Grace, 2011). 
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More than half of the aloe species have well-documented medicinal uses as well as 
being used for general well-being worldwide (Glen and Hardy, 2000). Currently the 
main source of these products is Aloe vera. Its use has even led to the creation of a 
massive multi-billion dollar industry (International Aloe Science Council, 2004). This 
business uses even the gel, mainly in cosmetics and to make tonic drinks (O’ Brien 
et al., 2011). The leaf pulp may be applied directly to the problem area without 
preparation to treat ring worm (Reynolds, 1950) or to dress wounds (Morton, 1961). 
The aloe-emodin as well as the anthraquinone content found in this species has 
been used as the main explanation for its therapeutic use as a laxative. Not many 
other aloe species have been extensively studied but A. ferox rapidly gained a lot of 
interest in the pharmaceutical industry after 1994 when its first gel was produced 
(Botha, 1994). The gel from A. ferox has been compared to that of A. vera, but some 
differences, mainly within the polysaccharides after hydrolysis, have been 
discovered (O’ Brien et al., 2011). A. vera only yields mannose, whereas different A. 
ferox species can either produce glucose only or galactose-glucose in a ratio of 1:1 
or 1:2 (O’ Brien et al., 2011). A. ferox has become one of the most interesting and 
studied aloes after A. vera and South Africa remains the largest exporter of this aloe. 
 
The name “aloe” is derived from the Greek word for its dried juice and “Ferox”, 
meaning “fierce”, is from the appearance of its leaves, which have spear-shaped 
edges. The other names of this plant include iKhala (Xhosa), iNhlaba (Zulu), 
bitteraalwyn (Afrikaans) and red aloe or bitter aloe (English) (O’ Brien et al., 2011). It 
grows up to 2 - 3 metres in height and has dull green leaves that cover the entire 
stem. Even after drying the leaves remain intact, forming a “petticoat”. The flowers 
are found in large numbers on a candelabra-like flower head, as shown on Figure 
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1.1. There are usually five to eight branches, each carrying a spike-like head of 
flowers whose colour varies from yellow-orange to bright red. 
 
Figure 1.1. Aloe ferox Mill. 
 
A. ferox is widely distributed on rocky hill slopes and is found from the South 
Western Cape through KwaZulu-Natal and the Free State to Southern Lesotho (Van 
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Wyk et al., 1997). Although the species is widely distributed, uncontrolled harvesting 
for private and local commercial use places it under threat of extinction (Kambizi 
 et al., 2005). This plant has a well-documented history of use as medication in 
different formulations. Its history goes so far back that there are some San rock 
paintings showing the plant and its uses (Grace, 2011; Reynolds, 1950). 
 
A. ferox has been reported to have therapeutic benefits and is widely used in the 
Cape, South Africa to treat some ailments (Shackleton and Gambiza, 2007). 
Traditional healers prescribe it as a water concoction to treat infertility in women and 
impotence in men (Grace et al., 2008). Although the discovery of its activity in 
absorbing ultraviolet (UV) light, especially UV B, was surrounded by controversy 
about addictiveness and hypersensitivity, these setbacks were dealt with. Lower 
concentrations of the gel compounds were used to test its safety and it was found to 
protect against solar radiation with no further problems (Grollier et al., 1987). The 
nectar from the flowers is often given to children to eat (Fox and Young, 1982) and it 
can be blended into fruit and other food supplements (Grace, 2011). 
 
Even with the high demand for products from the aloe species, only a few are used 
commercially. A. ferox has been shown to have as many as 86 uses as a therapeutic 
agent (Kambizi et al., 2005). Kambizi et al. (2005) isolated and identified 1, 1, 8-
dihydroxy -3–hydroxymethyl-9, 10-anthracenedione (Aloe- emodin), 2, 1, 8-
dihydroxy-3-methyl-9, 10-anthracenedione (Chrysophanol) and 3, 10-C-β-D-
glucopyranosyl-1, 8-dihydrocymethyl-9-anthracenone (Aloin A) from A.loe ferox. It is 
therefore important to determine if there are any more compounds that may be 
extracted from this plant and to determine their bioactivity.  
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1.2. Motivation for the study 
With a large number of organisms developing resistance to therapeutic agents in 
use, it is necessary to find effective and safer alternatives. Medicinal plants remain 
an important source of new drugs, new drug leads and new chemical entities. The 
therapeutic potential of Aloe ferox Mill. from the Asphodelaceae family has not been 
extensively studied, although this plant has been and is still being used locally to 
prevent, treat or manage different ailments such as arthritis, diabetes and sexually 
transmitted infections (STIs). 
 
1.3. Aim and objectives 
The aim of this study was to evaluate the potential of A. ferox Mill. as a source of 
novel therapeutic agents. 
 
Objectives 
The objectives of this project (Figure 1.2) were as follows; 
1. To determine the anti-cancer activity of aqueous, methanol and 
dichloromethane extracts of A. ferox. 
2. To determine the anti-microbial and anti-diabetic activity of the plant. 
3. To evaluate the cytotoxic potential of the methanol and aqueous extracts of A. 
ferox on normal cell lines. 
4. To separate and identify secondary metabolites from A. ferox by conducting 
qualitative and quantitative phytochemical tests. 
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1.4. Chapter overview 
The following chapters report on the anti- cancer activity, phytochemical 
composition, anti- diabetic, anti- microbial and antioxidant activity of the leaf extracts 
of A. ferox based on the information gathered from local traditional healers who 
commend this plant for its strength and value in traditional medicine. The safety of 
the plant extracts was also investigated against normal cell lines. All this was done to 
validate the eventual use of this plant. Initially, three extracts (aqueous, methanol 
and dichloromethane) of A. ferox were investigated. However due to lack of enough 
plant material to extract and the fact that dichloromethane did not extract much from 
the plant the dichloromethane extract was not studied in other chapters. 
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Figure 1.2. Flow diagram of the procedure to investigate the therapeutic potential of A. ferox leaf extracts.
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CHAPTER 2 
 
In- vitro anti-cancer activity of Aloe ferox Mill. 
 
2.1. Introduction 
Since the isolation and modification of the anti-cancer compound camptothecin from 
the Chinese plant Camptotheca acuminata in the 1960s (Dancey and Eisenhauser, 
1996; Wall and Wani, 1996), much progress has been made to improve cancer 
therapy. Camptothecin and its derivatives exerted their activity by targeting 
topoisomerase 1, an enzyme modulating DNA structure development (Dancey and 
Eisenhauer, 1996). Many synthetic and semi-synthetic derivatives of this compound 
have been developed and tested, and combinations of these derivatives were also 
investigated against cancer cell lines. Drugs such as tamofixen are believed to exert 
their effects through their antioxidant as well as anti-oestrogenic properties 
(Wiseman and Halliwell, 1996). Although they proved to have substantial activity, 
their toxicity remained a prime problem. More compounds have been discovered 
throughout the years since the first discovery, but their severe side effects such as 
anaemia, leukopenia and liver damage remain unchanged. Certain herbs have been 
suggested to reduce the side effects of current chemotherapy drugs and radiation 
therapy, perhaps by boosting immunity against cancer (Sakarkar and Deshmukh, 
2011).  
 
There are numerous ways in which drugs can function to avoid further damage or 
avoid damage by carcinogens in cancer therapy (Sakarkar and Deshmukh, 2011), 
some of which are listed below: 
1. Stimulation of phagocytosis, enhancing natural killer cell activity. 
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2. Inhibition of blood flow to the cancerous tissue, leading to necrosis and 
inhibited translocation. 
3. Promotion of apoptosis by increased production of elements leading up to the 
complement cascade. 
4. Enhancing the production of platelets and leucocytes activating the 
haemopoietic function. 
5. Promotion of metabolism, leading to inhibited metastasis and conversion of 
normal cells to tumour cells. 
6. Pain relief, appetite increase and promotion of good quality sleep, leading to 
improved health of the patient.  
 
It is therefore important to find alternatives or ways to overcome the toxicity side 
effect of the drugs used at present. Aloes have been found to contain the apoptosis-
inducing compound aloe- emodin and have been used since ancient times, as far 
back as 500 B.C. in Egypt; they were also mentioned by Dioscorides in the first 
century A.D. (Castleman, 1991). Consequently aloe emodin makes this plant a 
potential source of anti-cancer drugs, as apoptosis is the main focus for cancer 
therapy (Chui et al., 2009). This chapter focuses on testing the aqueous, methanol 
and dichloromethane extracts of A. ferox Mill. for anti-cancer activity against selected 
breast, prostate and colon cancer cell lines. 
 
2.2. Methods 
2.2.1. Sample preparation 
A. ferox was purchased from a nursery in Pretoria, South Africa. A voucher 
specimen (RM001) was kept for future reference in the Biomedical Technology 
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research laboratory at the Central University of Technology. The leaves were 
washed, oven-dried at 40ºC and then pulverised. Ten grams of the powdered plant 
material was then soaked separately in 150 ml of different solvents: purified water, 
methanol and dichloromethane, and shaken for 72 hours, after which the extracts 
were filtered through filter paper. The methanol and dichloromethane solvents were 
then removed through rotary evaporation at 35ºC and the water extracts were 
freeze- dried. Before screening for different activities, the extracts were re-dissolved 
into the appropriate solvents in accordance with the required concentrations and 
volumes for each assay. For anti-cancer activity screening the extracts were 
dissolved in dimethyl sulfoxide (DMSO). 
 
2.2.2. In- vitro anti-cancer activity screening 
The sulforhodamine B (SRB) assay method of Monks and colleagues (Monks et al., 
1991) was used to test the cancer growth inhibitory effects of the A. ferox Mill. 
extracts against three cancer cell lines, namely MCF7 (breast cancer), HTC116 
(colon cancer) and PC3 (prostate cancer). The human cancer cell lines were 
obtained from the National Cancer Institute (NCI) in the framework of a collaborative 
research programme between the Council for Scientific and Industrial Research 
(CSIR) and the NCI. The colon cancer cell line (HCT116) was obtained from the 
European Collection of Cell Cultures (ECACC). The cell lines were maintained in a 
monolayer cell culture at 37ºC, 5% CO2, 95% air and 100% relative humidity in 
Roswell Park Memorial Institute (RPMI) medium containing 5% foetal bovine serum, 
2 mM L-glutamine and 5 µg/ml gentamicin. 
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For the SRB assay, the cancer cells were inoculated on 96-well micro-plates at 
planting densities of 7 - 10 000 cells per well. The cells were then incubated at 37ºC 
for 24 hours, after which one plate was fixed with trichloroacetic acid (TCA). This 
plate was labelled the T0 and represented the measurement of cells inoculated in 
each plate before drug addition. The test extracts at different concentrations (6.25 – 
100 µg/ml) as per protocol were added to the other plates (Ti). The plates were then 
incubated for 48 hours, after which cold 50% TCA was used to fix viable cells to the 
bottom of each well. The cells were then washed, dried and dyed with SRB. Optical 
density measurements on a multi-well spectrophotometer were used to calculate the 
net cell growth percentage at 540 nm. Cells without any drug/extract added were 
used as the control; the blank was complete medium without cells and etoposide 
was used as the standard. The samples were ran in triplicate. 
 
 
Figure 2.1. Inoculation of cancer cell lines on RPMI (A), the cells being stained with 
SRB after inoculation (B), washing the plates with 50% TCA and (C) optical density 
measurement with a spectrometer (D). 
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The optical density of the test well after a 48-hour period of exposure to the test drug 
is Ti, the optical density at time zero is T0, and the control optical density is C. The 
following equations were used to calculate the percentage cell growth: 
[(Ti - T0)/(C - T0)] x 100 for concentrations at which Ti≥ T0. 
[(Ti - T0)/ T0] x 100 for concentrations at which Ti˂T0. (Monks et al., 1991). 
 
The biological activities of the five doses tested were reported as total growth 
inhibition (TGI) and divided into four categories, as shown in Table 2.1. 
 
Table 2.1.Criteria for biological activities of the extracts. 
 
 
2.3. Results and discussion 
According to the CSIR criteria (Table 2.1), the tested extracts (aqueous, methanol 
and dichloromethane) are all inactive against all the cell lines, as indicated in Figure 
2.2. They all had a TGI of more than 100 µg/ml against all the breast, colon and 
prostate cancer cell lines.  
TGI Category 
> 50 µg/ml Inactive 
< 50 µg/ml>15 µg/ml Weak Activity 
< 15 µg/ml> 6.25 µg/ml Moderate Activity 
< 6.25 µg/ml Potent Activity 
33 
 
 
Figure 2.2. Activity of methanol, dichloromethane and aqueous extracts of A. ferox against the breast cancer (MCF7), colon cancer 
(HCT116) and prostate cancer (PC3) cell lines. 
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Table 2.2 shows the results of all the parameters measured. As indicated, the methanol extract did show a lower GI50 
of86.56 µg/ml against the breast cancer cell line. The dichloromethane extract showed a 50% inhibitory concentration of 
46.09 µg/ml against the prostate cancer cell line, which is much lower compared to 86.72 µg/ml needed to exert the same activity 
against the breast cancer cell line. 
 
Table 2.2.The biological activities of A. ferox extracts against MCF7, HCT116 and PC3 cancer cell lines. 
 
 Aqueous Methanol extract Dichloromethane extract 
Activities MCF7 HCT116 PC3 MCF7 HCT116 PC3 MCF7 HCT116 PC3 
GI50 >100 >100 >100 86.56 >100 >100 86.72 >100 46.09 
TGI >100 >100 >100 >100 >100 >100 >100 >100 >100 
LC50 >100 >100 >100 >100 >100 >100 >100 >100 >100 
LC100 >100 >100 >100 >100 >100 >100 >100 >100 >100 
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Aloin, chrysophanol and aloe-emodin were isolated and identified from ethyl acetate, 
n-hexane and water leaf extracts of A. ferox by Kambizi et al., (2004). This was done 
after the leaf extracts had been partitioned and fractionated. However, of all these 
compounds, aloe-emodin is studied most frequently because of its activity of 
promoting apoptosis and production of anti-tumour effects (Kim et al., 1999; Chiu et 
al., 2009). Since cancer is a disturbance within the cell cycle, apoptosis is the best 
way to control or even completely eradicate tumorous tissues. Thus apoptosis is the 
main focus whenever one is looking for anti-cancer agents (Chiu et al., 2009). In 
conjunction with cell death promotion, aloe-emodin has antiviral, antimicrobial and 
hepatoprotective activities (Lu et al., 2007; Eshun and He, 2004). Kuo et al. (2002) 
also studied the activity of aloe-emodin against HepG2 and Hep3B and found that it 
can induce its anti-cancer effects through either the p53 or p21 dependent apoptotic 
pathways. It also exhibited selective activity against neuro- ectodermal tumours and 
no activity against normal cells (Pecere et al., 2000). The emodin can be used 
against these tumours and also against Merkel cell carcinoma in conjuction with 
cisplatinol, a chemotherapeutic agent (Fenig et al., 2004). The anti-coagulant/anti-
thrombotic activity of this plant in conjunction with the anti-cancer activity makes it an 
ideal choice for the treatment of cancer and also presents with a hyper-coagulable 
state at some stages of the disease (Grace, 2011).  
 
The results from this investigation, however, do not correlate with the literature. The 
extracts were inactive against the cancer cell lines used, despite the fact that local 
traditional healers as well as other scientists believe that it can manage and even 
cure different cancers. There could be numerous reasons for the results being 
negative in this instance. Firstly, the cell lines were tested against impure crude 
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extracts at microgram concentrations. It is possible that if the extracts had been 
fractionated and tested against the cell lines separately, the results might have been 
positive and corresponded with other findings. Factors such as the age of the plant 
play a major role in the amounts of aloe polysaccharides and flavonoids available as 
well, which might also explain the difference in the results from what has previously 
been published (Hu et al., 2003). 
 
2.4. Conclusions 
A. ferox has many other health-boosting properties that have been studied and that 
may aid in the management of cancer. This may explain why traditional healers get 
good results after prescribing the crude extract to their patients. Thus the extracts 
may be functioning through other mechanisms that were not the focus of this study, 
such as improving metabolism, enhancing appetite, relieving pain and acting as a 
general immune boaster, minimising the symptoms and the pathology of the disease.  
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CHAPTER 3 
 
The in- vitro anti-diabetic activity of Aloe ferox 
 
3.1.  Introduction 
Enzymatic and non-enzymatic antioxidant mechanisms in the body sometimes fail to 
reduce the reactive oxygen species that cause many degenerative diseases such as 
diabetes (Patel et al., 2012). Other mechanisms to rid the body of these harmful 
reactive oxygen species (ROS) are eagerly sought and should be well studied and 
identified. Collier et al. (1990) state that oxidative stress in diabetes coexists with a 
reduction in antioxidant concentrations. The accumulation of free radicals such as 
alloxan can lead to damage of the pancreas, furthering the complications. The 
damage would lead to reduced function and availability of the beta cells of the 
pancreas. With fewer beta cells there will be no binding of insulin and glucose, 
leading to hyperglycaemia. Thus antioxidant- rich diets can reduce oxidative stress 
and reduce the glycosylated haemoglobin in diabetic patients (Valko et al., 2007).  
 
Recent research is targeted at discovering anti-diabetic agents that are safe, with 
fewer or no side effects. Current anti-diabetic therapies, such as acarbose and 
metformin, act on the liver and have severe negative side effects, such as hepatic 
dysfunction at high doses (McCue et al., 2005). Some ultimately lead to sorbitol 
accumulation, resulting in neuropathy and nephropathy (Lee, 2002). There are 
already many plants that are used across the world to treat and manage diabetes. 
Some of them are used traditionally, whereas others have already been made into 
formulations and sold as herbal preparations in pharmacies. Table 3.1 shows a list of 
plants that are used for diabetes. The listed plants are found across the world. Some 
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of them are native to India, such as Andrographis paniculata and Allium sativum, 
whereas others are from as far as Pakistan (Azadirachta indica) (Kavishankar et al., 
2011). Medicinal plants can be cultivated or found in nature, but their importance 
remains universal. As one of the locally used plants as a way to manage diaetes, 
Aloe ferox has to be studied to establish its effectiveness regarding blood glucose 
reduction in diabetic patients. The glucose uptake models to be used in this chapter 
will establish whether A. ferox enhances, inhibits or has no effect on glucose uptake 
by cells in- vitro which is the mechanism through which blood glucose is reduced and 
utilized by muscle and other cells in the body. 
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Table 3.1. Medicinal plants used as treatment for diabetes. 
Scientific name Family Parts used References 
Andrographis paniculata Acanthaceae Leaves Dandu and Inamdar, 2009; Zhang and 
Tan, 2000. 
Azadirachta indica Meliaceae Leaves Wadood et al., 1989. 
Prunus serotina Roseaceae Bark McCune and Johns, 2007. 
Aegle marmelos Rutaceae Leaves Ponnnachan et al., 1993. 
Aloe vera Liliaceae Leaves  
 
Okyar et al., 2001. 
Allium sativum Lilliceae Leaves Eidi et al., 2005. 
Solidago canadensis Asteraceae Bark McCune and Johns, 2007. 
Allium cepa Alliaceae Bulb onion Mathew and Augusti, 1975. 
Eclipta alba  Asteraceae Leaves Ananthi et al., 2003 
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Origanum vulgare  
 
Lamiaceae Leaves Lemhandri et al., 2004. 
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3.2. Methods 
3.2.1. Sample preparation 
The plant extracts were prepared as described in Chapter 2 section (2.2.1). 
 
3.2.2. The C2C12 in- vitro model of glucose uptake 
The C2C12 muscle cells were grown in Dulbecco's Modified Eagle Medium (DMEM) 
with 10% foetal bovine serum at 37ºC in humidified air with 5% CO2. The cells were 
then placed in 96-well plates at a density of 4 000 cells per well and incubated for 
three days, after which 2% horse serum was supplemented into the cells after a 
further two days of differentiating the cells. The cells were then put in modified 
DMEM supplemented with 8 mM glucose and treated with methanol and water at 
50 µg/ml, metformin (1µM), insulin (1µM) or solvent for the control. The plates were 
then incubated for three hours, after which the concentration of the remaining 
glucose was determined using a commercial fluorimetric kit. This was done to 
determine glucose uptake by the cells at a cell passage number of lower than 10. 
 
3.2.3. The Chang cell in-  vitro model of glucose uptake 
Chang cells were grown and maintained in Eagle’ s Minimal Essential Medium 
(EMEM) at 37ºC with 10% foetal bovine serum with 5% CO2 humidified air. The cells 
were then planted into 96-well plates at planting densities of 6 000 cells per well and 
incubated for five days. The cells were then put in modified EMEM supplemented 
with 8 mM glucose and treated with the extracts (50 µg/ml), metformin (1 µM), insulin 
(1 µM) or solvent for the control. The plates were then incubated for three hours at 
37ᵒC and the concentration of the remaining glucose was determined using a 
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commercial fluorimetric kit. This was done to determine glucose uptake by the cells 
at a cell passage number of lower than 10. 
 
3.3. Results and discussion 
After addition of the extracts, there was a greater increase in glucose levels in 
C2C12 cells than the vehicle control (Figure 3.1). The methanol extract raised the 
glucose levels from 100 µg/ml (control) to 109.57 µg/ml, whereas the aqueous 
extract raised it to 134.00 µg/ml. The extracts were, however, less effective with the 
Chang cells, where a slight decrease in glucose levels was observed after the 
extracts were added. The aqueous extract decreased glucose to around 90 and 98 
for the methanol extract. The results showed that the extract was more effective in 
enhancing glucose uptake in muscle cells more than the Chang cells. 
 
These results correlate with the statement by Van Wyk et al. (2009) that locally this 
plant is known as a blood purifier and is widely used by locals in cases of high blood 
pressure and acne, among other blood-related disorders. Other plants from the 
Asphodelaceae family are widely used to manage diabetes. The most common is A. 
vera, which has been formulated into drinks and pills. According to Hui (Hui et al., 
2009) medicinal plants function through enhancement of insulin release, increasing 
glucose uptake by muscle and adipose cells.  
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Figure 3.1. Glucose uptake of the two cell lines (C2C12 and Chang cells) after treatment with A. ferox extracts.
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3.4. Conclusions 
A. ferox is an encouraging possible source of a new anti-diabetic agent, as proven 
by the results. This finding is very encouraging, as it validates the use of this plant for 
diabetes, even more so as the aqueous extract proved to be more effective than the 
methanol extract. The local belief that it is a blood purifier has been proven correct. 
More investigations are highly recommended to determine the mechanism of action 
of these extracts. This may lead to a broad study of the plant and eventually the 
formulation of clinically approved drugs. 
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CHAPTER 4  
Anti-bacterial and anti-fungal activity of Aloe ferox 
4.1. Introduction 
Possible sources of antimicrobial drugs are those that can inhibit the growth of or kill 
pathogens with little or no toxicity towards host cells (Masoko et al., 2005). Synthetic 
drugs are continually becoming useless against pathogens, be these bacteria, fungi 
or viruses. They are increasingly developing resistance at a rate higher than the 
discovery of new alternatives (Marr et al., 1997; Dannaoui et al., 2001). Examples 
include the drug-resistant Mycobacterium tuberculosis strains, human 
immunodeficiency virus (HIV) and penicillin-resistant bacteria. There have been an 
increasing number of reports about the discovery of medicinal plants with 
antibacterial, antifungal and antiviral activity in recent years (Cowan, 1999). Most of 
the medicinal properties are found to be from higher plants (Masoko et al., 2005) and 
they are used worldwide to treat different ailments (Mitscher et al., 1987). They are 
prescribed by traditional healers and it is ideal for their traditional use to be 
supported by pharmacological and scientific proof (Locher et al., 1995). 
 
Sexually transmitted infections, also known as venereal diseases, are the most 
common problem faced by South African society and are also regarded as the 
ailments that are most responsive to traditional treatment (Buwa and van Staden, 
2006). The most commonly known venereal diseases (Buwa and van Staden, 2006) 
include gonorrhoea, syphilis and candidiasis. These have been implicated in the 
increased risk of acquiring and transmitting HIV (Buwa and van Staden, 2006). It is 
therefore important to treat these before they propel the HIV epidemic in Africa 
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further (Grosskurth et al., 1995). Because of their good responsiveness to traditional 
medicine, they are the ailments most commonly treated by traditional healers. A. 
ferox, as an infusion is the main plant prescribed by traditional healers for the 
treatment of such diseases, especially in the Eastern Cape Province. 
 
It is therefore fitting that this chapter focuses on exploring the anti-bacterial and anti-
fungal activities of A. ferox methanol extracts. The aqueous extract was not tested 
for these activities due to lack of test material. The ability of this extract to inhibit the 
growth of selected bacterial and fungal strains was evaluated, using the micro-
dilution method. 
 
4.2. Methods 
4.2.1. Micro-dilution method 
The methanol extract of A. ferox was prepared as mentioned in Chapter 2 (2.2.1.). 
The extract was screened for anti-bacterial and anti-fungal activity through the micro-
dilution technique developed by Eloff (1998). Different concentrations of the test 
extract (15 mg/ml- 3 mg/ml) were prepared and 100 µl of each concentration was 
added to the 96-well micro-plates, as seen in figure 4.1. One hundred microlitres of 
the diluted (1: 100) three-hour-old culture of Streptococcus pneumonia (ATCC 
49619), Staphylococcus epidermidis (ATCC 12228), Enterococcus faecalis (ATCC 
89212), Escherichia coli (ATCC43888), Candida albicans (ATCC90028) and 
Candida tropicalis (ATCC750) in Muller Hinton broth was added to these 96-well 
micro-plates. Chloramphenicol was used as a standard drug for all organisms. The 
micro-plates were covered and incubated overnight at 37ºC. The tests were run in 
triplicate for each concentration. 
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To indicate growth after 24 hours of incubation, 40 µl of p- Iodonitrotetrazolium violet 
(INT) [Sigma] solution was added to each well. The plate was then incubated at 37ºC 
for 10 - 30 minutes. Growth was indicated by colour change ranging from pink to 
violet. Since fungi grow more slowly than bacteria, these were incubated for 36 hours 
before observing for growth after addition of the INT indicator. The MIC signifies the 
concentrations at which there was no bacterial growth observed. 
 
 
 
Figure 4.1. Bacteria inoculated into 96 microwell plates: (A) Plates with media and 
methanol extract only; (B) after inoculation of bacteria. 
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4.3. Results and discussion 
As shown in Table 4.1, the tested extract did not completely inhibit the growth of the 
E. faecalis and C. tropicalis strains tested against, even at the highest concentration 
of 15 mg/ml. The violet colour (Figure 4.2) shows growth of the bacteria at different 
concentrations. It was however effective against Staph epidermidis and C. albicans 
at concentrations of 15 mg/ml and 13 mg/ml and only effective at 13 mg/ml against 
Strep pneumonieae and E. coli. These findings of activity, even if weak in most parts, 
correlate with the findings of Kambizi et al., (2004). A. ferox showed antimicrobial 
activity against Bacillus cerus, Bacillus subtilis, Staphylococcus aureus, 
Staphylococcus epidermidis, Shigella sonnei and Escherichia coli. This activity is 
important, as some bacteria, such as E. coli, have been associated with specific 
cancers such as colon cancer. It is through these kinds of results that the true value 
of this plant in the cosmetic industry was discovered. Some of the bacteria can be 
fatal in seemingly harmless infections such as septicaemia and other nosocomial 
infections in susceptible immune-compromised patients. The aloin that makes up 
most of the aloe leaf exudate is said to be important in determining the degree of 
activity against bacteria; its glycoside content enables it to invade bacterial cells 
easily (Niciforovic et al., 2007). Plants from the Aloe species are mainly used as 
treatment for STIs such as herpes, syphilis, gonorrhoea and candidiasis and also for 
the treatment of internal parasites (Grace et al., 2008). 
 
Though concentrations as high as 15 mg/ml were required to inhibit bacterial growth, 
this could be explained as a result of the state of the extract used. Crude extracts 
usually contain only a low concentration of the active compounds and more of other 
materials that are inactive. It is possible that the extracts will exhibit a much stronger 
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activity after purification. That could be achieved by isolating the compounds 
separately and testing them for anti-microbial and anti-fungal activity. 
 
Table 4.1. Minimum inhibitory concentration (MIC) of the A. ferox methanol extract 
against the bacterial and fungal strains. 
Bacterial/ fungal strain MIC (mg/ml) 
Staphylococcus epidermidis 13 
Streptococcus pneumonieae 15 
Escherichia coli 15 
Escherichia faecalis >15 
Candida albicans 15 
Candida tropicalis >15 
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Figure 4.2.  Photograph showing fungal and bacterial growth after treatment with extracts at different concentrations and incubation 
(A) Candida albicans and Candida tropicalis, (B) Escherichia coli and Escherichia Faecalis and (C) Staphylococcus epidermidis 
and Streptococcus Pneumonia 
55 
 
4.4. Conclusions 
The fact that this plant is effective against vastly different organisms, from viruses 
and bacteria to fungi, further stresses its value. The activity could be credited to 
compounds such as phenols, aloesin, alkaloids and steroids found in the extracts. 
These results, however, show that history and the knowledge passed on through 
generations are right, as the plant does inhibit growth, even if not in all the bacterial 
strains used. 
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CHAPTER 5 
 
In- vitro cytotoxicity of methanol and aqueous extracts of Aloe 
ferox 
 
5.1.  Introduction 
According to Balick et al., (1996) the chance that an active ingredient in any drug is 
from plants is one in four. Although plants are rich in pharmaceutically relevant 
compounds, they can also be dangerously toxic to the human body.  Since there is 
so much interest in medicinal plants, measures have to be put in place to ensure that 
they are effective and safe for use. Traditional healers prescribe these plants to the 
public with no scientific validation of their efficacy and safety. 
 
Misidentification, incorrect preparation, administration and dosage are the main 
causes of poisoning and in some cases death from plants used for medicinal 
purposes (Stewart and Steenkamp, 2000; Fennell et al., 2004). There are currently 
no regulations in place for the prescription and use of traditional medicine in South 
Africa (Fennell et al., 2004). That could be the reason for the estimated 8 000 to 
20 000 deaths per annum that result from poisonous plants (Thomson, 2000). For 
instance, between 1991 and 1995 about 43% or perhaps even more (Popat et al., 
2001) of all reported poisoning cases in Johannesburg were due to supposedly 
medicinal plants (Stewart et al., 1999). 
 
Plants such as Iboza riparia (Bodenstein, 1977; Fennell et al., 2004), Cryptocarya 
latifolia, Synadenium cupulare (Fennell et al., 2004) and Callilepis laureola 
(Wainwright and Schonland, 1977; Popat et al., 2001) have already been established 
as toxic to the human body. These are plants that were previously believed to be 
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beneficial in the treatment of different ailments. For example, Callilepis laureola was 
discovered after years of traditional use to be the cause of the high incidence of liver 
necrosis among most of the KwaZulu-Natal population in the 1970s (Wainwright and 
Schonland, 1977). Like many of the above-mentioned plants, A. ferox is well known 
and used often to treat different ailments. This can be done through self-
administration, with no information on the health risks, proper mode of administration 
and more importantly, appropriate dosages. It is for that reason that the cytotoxic 
potential of A. ferox was studied.  
 
This chapter focuses on testing the toxicity of A. ferox water and methanol extracts 
against normal cell lines, namely C1C12 muscle cells, Chang cells and the W138 
normal human foetal lung fibroblast. 
 
5.2. Methods 
5.2.1. Sample preparation 
Two extracts were selected and further tested for cytotoxicity against normal muscle 
and Chang cells. The methanol and aqueous extracts of A. ferox were prepared as 
described in Chapter 2 (2.2.1). They were then dissolved in their respective solvents, 
i.e. methanol and distilled water, to make up the required concentrations for the 
assays. 
 
5.2.2. Mosmann Tetrazole Test (MTT) cytotoxicty activity assay on 
muscle and Chang cells 
The MTT cytotoxicity test is based on the colour reaction of mitochondrial 
dehydrogenases from living cells (Valko et al., 2006). The assay was done with 
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modifications, as previously described (Mosmann, 1983). The C2C12 muscle cells 
were grown in DMEM with 10% foetal bovine serum at 37ºC in humidified air with 5% 
CO2. The cells were then placed in 96-well plates at a density of 4 000 cells per well 
and incubated for three days, after which 2% horse serum was supplemented into 
the cells after a further two days of differentiating the cells. Simultaneously Chang 
cells were grown and maintained in EMEM at 37ºC with 10% foetal bovine serum 
with 5% CO2 humidified air. The cells were then planted into 96-well plates at 
planting densities of 6 000 cells per well and incubated for five days. After incubation 
of both the C2C12 and Chang cells the methanol and water extracts at 5 µg/ml were 
added to the relevant wells. The covered plates were then incubated for 48 hours at 
37ºC. 
 
5.2.3. Sulforhodamine B  assay  
The SRB assay (Monks et al., 1991) was done to test the cytotoxic activity of A. 
ferox methanol and aqueous extracts against a selected normal cell line. W138 
(normal human foetal lung fibroblast from ECACC) cell line was maintained as a 
monolayer at 37ºC, 5% CO2 and 100% relative humidity in EMEM with 10% foetal 
bovine serum, 2 mM L-glutamine and 50 µg/ml gentamicin. The cells were then 
inoculated into 96- well plates (densities of 10 000 cells/well) and incubated for 24 
hours at 37ᵒC. The cells were then treated with the test extracts at five different 
concentrations ranging from 6.25 - 100 µg/ml (5 x twofold serial dilutions). Etoposide 
was used as the standard drug, cells without drugs served as the control and 
medium with no cells as the blank. The plates were incubated for 48 hours at 37ᵒC, 
after which viable cells were fixed to the bottom of each well with cold 50% 
trichloroacetic acid, washed, dried and dyed with SRB. Tris (10 mM) was used to 
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remove the protein-bound dye for optical density determination at 540 nm using a 
multiwall spectrophotometer. The optical densities were used to determine the IC50 
(µg/ml) for each extract. 
 
5.3. Results and discussion 
The test extracts had no toxic side effects on either the C1C12 or the Chang cells. 
The methanol extract caused an increase in MTT activity (percentage cell viability), 
whereas the aqueous extract only caused a slight and insignificant decrease in MTT 
activity on the Chang cells (Figure 5.1b) from 100 to 97.7. The methanol extract 
performed very well against the C1C12 cell line, as there was no significant change 
at all in the cell viability when compared to that of the positive control (Figure 5.1a). 
The aqueous extract did, however, cause a slight decrease in C2C12 cells from 100 
to 90.1 activity. The decrease is considered insignificant, as it is less than 15%. It 
was noticed that in both C2C12 and Chang cells the methanol extract performed 
even better than insulin and metformin. To date there has not been any scientific 
report of adverse effects of aloes in humans. It is, however, possible that A. ferox 
may be toxic at high concentrations, especially when used regularly in young 
children. It is also safe to assume that regular use of this plant as a laxative is 
harmful, as it could lead to disruption of the normal functioning of the digestive 
system. This means that more research has to be done to validate each species.
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Figure 5.1. Cytotoxic activity (MTT) of the methanol and aqueous extracts of A. ferox 
Mill. against the C1C12 muscle cell line (A) and  Chang cells (B).
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Table 5.1. CSIR criteria for cell cytotoxicity and A. ferox extract results. 
IC50 (µg/ml) Status 
Methanol extract 
(A. ferox) 
Aqueous extract 
(A. ferox) 
> 100   Low Hazard 
>100 >100 
< 100 > 30  Weak Hazard  
  
< 30  >5 Moderate Hazard 
  
<5  High Hazard 
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Figure 5.2. Cytotoxic effects of the methanol and aqueous extracts on viability of W138 cells. (A) represents the etoposide, (B) 
represents the A. ferox methanol extract and (C) represents the A. ferox aqueous extract. 
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According to the CSIR criteria, using the SRB method the two A. ferox extracts 
tested did not exhibit any toxicity against normal human foetal lung fibroblasts. The 
concentration required to reduce the percentage cell viability by 50% was more than 
100 µg/ml (Table 5.1) for both the methanol and aqueous extracts. Although the 
aqueous extract (Figure 5.2 C) showed a higher cytotoxic activity than the methanol 
extract (Figure 5.2 B), it also failed to reduce the cell viability to 50% even at its 
highest concentration, still rendering it safe for use.  
 
5.4. Conclusion 
The investigation shows that the extracts are safe for use by humans, as they 
exhibited no toxicity against the cell lines. The results are very encouraging and 
validate the use of this plant by traditional healers. The A. ferox plant extracts 
performed very well as they exhibited no toxicity in a way close to that of insulin and 
metformin which are drugs that are currently clinically prescribed for diabetes. This is 
a preliminary investigation and more needs to be done to confirm the safety of the 
plant definitely and determine the lethal doses of both extracts.  
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CHAPTER 6 
 
Phytochemical content of Aloe ferox Mill. 
 
6.1. Introduction 
Secondary metabolites such as alkaloids, tannins, flavonoids and phenolic 
compounds constitute the most bioactive compounds in plants (Hill, 1952; Edeoga et 
al., 2005). They exert their pharmacological effects either separately or in a 
synergetic way. The largest class of secondary plant compounds is alkaloids 
(Barbosa- Filho et al., 2006). They all have the same basic structure, usually 
comprising one or more nitrogen atoms, often in combination as part of the cyclic 
system (Harbone, 1991; Barbosa- Filho et al., 2006). 
 
Flavonoids, which were originally recognised as the pigments responsible for the 
different shades (yellow, orange, and red) in flowers and food, are found in all 
vascular plants. They have been proven to have anti-inflammatory, antioxidant, anti-
allergic, hepatoproliferative, antithrombotic, anti-viral and anti-carcinogenic activities 
(Middleton et al., 2000). The other groups of compounds that are of great interest in 
the pharmaceutical industry are steroids and steroidal saponins. Because of the 
relationship between steroids and sex hormones, the steroidal structure could be the 
starting point for the synthesis of these hormones (Okwu, 2001). Sometimes steroids 
present themselves as saponins, which can be classified into triterpenoids and 
steroidal saponins, with both groups having important pharmacological effects on 
mammalian cells. Triterpene saponins have anti-inflammatory, anti- tussive, 
expectorant, cytotoxic and analgesic activity, whereas steroidal saponins deal mostly 
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with hormone synthesis as precursors for androgens, oestrogen and progestrins, as 
well as anti-inflammatory agents (Gurib- Fakim, 2006). 
 
To maintain a healthy biological system there has to be a balance between oxidation 
and anti-oxidation (Hong and Liu, 2004; Katalinic et al., 2006; Pak et al., 2006). ROS 
and RNS are found in most of the disease states such as inflammatory infections, 
diabetes and cancer. Antioxidants directly remove ROS-mediated reactions, hence 
they can be used to prevent and treat these and other aging-related diseases. This 
inspires the search for antioxidant active drugs and drug leads; since all higher 
plants have some level of this activity, they are of great interest in this search. 
 
Plants and herbs have been used for their therapeutic activity since ancient times 
and are still used in this way (Madsen and Bertelsen, 1995; Wangensteen et al., 
2004). The therapeutic activity of such plants and herbs has been credited to the 
presence of compounds such as vitamins, terpenoids and polyphenols. These 
compounds function through different mechanisms, the most intensively studied 
being free radical scavenging (Suhaj, 2006; Albano and Miguel, 2010; Rice-Evans et 
al., 1996). Reports show that medicinal plants contain much more antioxidant 
compounds than dietary plants (Wong et al., 2006; Bouayed et al., 2006), which may 
explain their advanced therapeutic activities.  
 
Most of the drugs currently used as treatment for inflammatory and chronic diseases 
have adverse effects and require long-term administration in order to take effect 
(Conforti et al., 2008). The common synthetic antioxidants such as butylated hydroxy 
toulene and Butylated hydroxy anisole have severe side effects, such as internal and 
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external haemorrhaging and carcinogenesis (Ito et al., 1986).It is for these reasons 
that the pharmaceutical industry is seeking natural sources for medicine and 
antioxidants. However, a diet rich in vegetables is still a common recommendation, 
as it goes a long way in maintaining a healthy balance and preventing diseases.  
 
The Aloe genus is known for its rich anthraquinone compounds, such as 
chrysophanol, aloin, aloe- emodin and other aloe derivatives. These are very 
promising anti-cancer agent sources, as they cause cell death (Lu and Chang, 
2009). A. ferox alone has over 80 recorded medicinal uses. Most of the information 
available was obtained from local healers. However, more has to be done to validate 
these uses and one of the most important steps is determining the individual 
compounds present in the plant. This chapter focuses on determining the 
phytochemical makeup and antioxidant activity of A. ferox methanol extracts through 
a number of techniques. The total phenolic content was determined for the methanol 
as well as aqueous extracts of A. ferox. 
 
6.2. Methods 
6.2.1. Sample preparation 
The methanol extract was prepared in the same way as explained in Chapter 2 
(2.2.1). However for the determination of the total phenolic content, the aqueous, 
methanol and dichloromethane extracts were all re-dissolved in the respective 
solvents that were used to extract them. Dichloromethane and water were not very 
effective in extracting compounds from the plant leaves hence they were not used in 
the rest of the chapter as this lead to shortage of extract material. The solvents were 
added in accordance with the protocol to prepare the specified concentrations. 
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6.2.2. Qualitative assays 
Different qualitative methods adapted from De et al., (2010) were used to determine 
the phytochemical make-up of A. ferox extract and the antioxidant activity was also 
evaluated.  
 
Test for carbohydrates: Fehling’s test 
To 2 ml of the sample, 2 ml of Fehling’s reagent A and B was added. The solution 
was then shaken and boiled. The formation of a brick-red precipitate (cuprous oxide) 
indicated the presence of reducing sugars (De et al., 2010). 
 
Test for steroids: Libermann- Buchard test 
A few drops of acetic anhydride were added to treat the extract, the mixture was 
boiled and then cooled. Sulphuric acid was added to the mixture drop by drop down 
the sides of the test tube. The presence of steroids was indicated by the formation of 
a brown ring at the junction of the two layers with the upper layer turning green. 
Formation of a deep red colour at the upper layer indicated the presence of 
triterpenoids (De et al., 2010). 
 
Test for saponins: The foam test 
Two millilitres of the extract was mixed with 2 ml of distilled water and the solution 
was shaken vigorously. The formation of persistent foam was an indication of the 
presence of saponins in the extract (De et al., 2010). 
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Test for alkaloids: Dragendorff’s test 
The extract was mixed with a few millilitres of Dragendorff’s reagent. Alkaloids give a 
reddish brown precipitate (De et al., 2010). 
 
Test for flavonoids: Shinoda’s test 
Flavonoids give a pink, scarlet, green or green to blue colour after addition of a few 
fragments of magnesium ribbons and the drop-wise addition of concentrated 
hydrochloric acid (De et al., 2010). 
 
6.3. Quantitative assays 
6.3.1. Determination of total phenolic content: Folin Ciocalteu method  
The total phenolic content of A. ferox extracts was determined using the Folin-
Ciocalteu method according to Lowman and Box, (1983) with a few modifications. 
Gallic acid, which is a strong antioxidant, was used as the standard from which the 
phenolic concentration of the sample was determined and expressed as milligram 
Gallic acid equivalent (GAE). The methanol and aqueous extracts of A. ferox (0.1 ml) 
were mixed with 46 ml of distilled water in a 50 ml volumetric flask and 1 ml of Folin-
Ciocalteu reagent was added. The mixture was then thoroughly mixed and allowed 
to react for three minutes, after which it was topped up to 50 ml with sodium 
carbonate solution (2%). Then the solutions were allowed to incubate for two hours 
at room temperature. The absorbance of the solutions was measured at 760 nm. 
The same procedure was followed for Gallic acid at different concentrations (0.039 - 
2.5 mg/ml) to obtain the standard curve. 
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6.3.2. Determination of antioxidant activity: DPPH radical scavenging 
activity 
The method described by Brand-Williams et al., (1995), with some modifications, 
was used to screen the methanol A. ferox extract for antioxidant activity. A stable 
radical 2, 2-dipheny-1-picrylhydrazyl (DPPH) at 0.1 mM was used to investigate the 
free radical scavenging activity of the extracts. This was compared to that of ascorbic 
acid, a known antioxidant. One hundred millilitres of methanol solutions of the extract 
at various concentrations (0.078, 0.156, 0.3125, 0.625, 1.25 and 2.5 mg/ml) was 
added to 2 ml of the DPPH solution. The mixtures were shaken vigorously and then 
incubated in the dark at room temperature for one hour. The absorbance (Abs) of the 
solution was then measured at 517 nm, and the percentage of antioxidant activity 
(AA) calculated using the following formula: 
 
AA% = 100-{[(Abssample–Absblank) x 100]/Abscontrol} (Brand-Williams et al., 1995) 
(Abs= absorbance) 
A solution of methanol (0.1ml) and DPPH (2 ml) was used as the control and to 
blank methanol was used. The IC50 for the sample was determined from a plotted 
graph of DPPH disappearance as a function of sample concentration. 
 
6.3.3. Liquid chromatography mass spectrometry (LCMS) analysis 
The following set-up was used for the LCMS analysis of the A. ferox methanol 
extract: 
1. A Waters Synapt G2 UPLC with a Waters UPLC BEH C18, 2.1 X 100 mm 
column. 
2. A flow rate of 0.4 ml/min. 
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3. Use of (1) 0.1% formic acid to acetonitrile gradient and (2) water as eluting 
solvents. 
4. Negative electrospray at a capillary voltage of 3 kV and cone voltage of 15 V. 
5. Running time of 15 minutes. 
 
6.3.4. Gas chromatography mass spectrometry (GCMS) 
The following method/set-up was used for the GCMS analysis of the methanol 
extract of A. ferox: 
1. The initial temperature was set at 50ºC for five minutes 
2. Ramped at 3ºC per minute to 100ºC for 10 minutes. 
3. The inlet temperature was 200ºC with splitless flow mode. 
4. The carrier gas was helium at 1 ml/min flow rate. 
 
6.4. Results and discussion 
The aqueous plant extract showed the presence of carbohydrates, saponins, 
steroids, alkaloids as well as flavonoids. The presence of steroids and alkaloids 
strongly suggest that these methanol and aqueous extracts of A. ferox may have 
potential in the production of anti-inflammatory or even anti-cancer agents. Any 
agent that has steroids and alkaloids is a strong contender in the fight against cancer 
and other chronic inflammatory diseases, as most of these compounds have been 
found to have anti-inflammatory, free radical scavenging and apoptosis-inducing 
properties (Furusawa and Wu., 2007). The presence of saponins may also indicate 
the presence of steroids and triterpenoids, which is often present in the form of 
saponins (Haralampidis et al., 2002). The pharmacological effects of plants are a 
result of the activity of single compounds or a synergetic effect of the compounds 
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(Eloff et al., 2008). The presence of flavonoids also contributes to the antioxidant 
activity of plant extracts, as in addition to free radical scavenging, they also have 
vein-strengthening effects (Van Wyk et al., 2004). They have anti-inflammatory, anti-
allergic, anti-bacterial and anti-viral effects (Middleton et al., 2000). Findings by 
Kambizi (Kambizi et al., 2004) are supported by the results of the present study. The 
above-mentioned findings correlate with those of Loots et al., (2007). 
 
Table 6.1 shows the variation in the total phenolics of the three different extracts 
analysed at 5 mg/ml against Gallic acid. The phenolic content varied between the 
extracts with the methanol extract showing more polyphenols than the aqueous and 
dichloromethane extracts. The GAEs of the estimated phenolic concentrations range 
from 0.340 ± 0.057 to 0.726 ± 0.032 mg/ml GAE. These findings support those of 
Loots et al., (2007) that A. ferox is a rich source of different phenolic compounds. It 
can be postulated that their presence is part of the mechanisms that make this plant 
such a valued part of local herbal medicine. 
 
Table 6.1.Total phenolic content of A. ferox extracts.  
Sample Absorbance 
Mean 
Polyphenol 
concentration (GAE) 
 
Aqueous extract  
5 mg/ml 
0.069 0.340 ± 0.057 
Dichloromethane 
5 mg/ml 
0.109 0.550 ±0.042 
Methanol extract  
5 mg/ml 
0.144 0.726 ± 0.032  
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The DPPH radical scavenging activity of the methanol extract of A. ferox is shown in 
Table 6.2. Only the methanol extract was evaluated for the antioxidant activity since 
it showed the best results with the highest phenolic content (Table 6.1).  This was 
also done to preserve the aqueous extract as there was a shortage of the plant 
material for extraction. The methanol extract has potent antioxidant activity, which 
was compared to that of a known standard, ascorbic acid (Figure 6.1). The highest 
activity (101 ± 0.042%) was achieved at a concentration of 2.5 mg/ml. The EC50 of 
the extract was 0.865 mg/ml compared to that of ascorbic acid, which was 
0.042 mg/ml. At a concentration of 1.25 mg/ml, more than 75% of DPPH was 
scavenged, which is massive activity that might be able to go a long way in delaying 
or preventing the disease process and restoring the oxidative balance. 
 
Table 6.2. % DPPH scavenging activity of A. ferox extracts.  
Concentration (mg/ml) % DPPH scavenging activity 
2.5 101.25 ± 0.042 
1.25 75.87 ± 0.386 
0.625 52.98 ± 0.416 
0.3125 29.92 ± 0.699 
0.156 21.38 ± 0.252 
0.078 12.61 ± 0.682 
EC50 (mg/ml) 0.865 ± 0.783 
Ascorbic acid EC50 (mg/ml) 0.042 ± 0.084 
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Figure 6.1. Free radical scavenging activity of methanol extract of A. ferox (B) 
compared to ascorbic acid (A) control. 
  
Because of the presence of free radicals in almost all human disease states and the 
free radical scavenging activity of this plant is of great significance and importance. 
Compounds with free radical scavenging activity have been shown to prevent 
oxidative damage to tissues and significantly improve wound healing, among other 
effects (Svobodová et al., 2006). Therefore these results might validate the use and 
value of A. ferox by traditional healers for the treatment of different ailments such as 
diabetes and prevention of the development and progression of cancer. 
 
Numerous studies have been done to investigate the relationship between the 
polyphenol content and antioxidant activity of different plants. It is clear from the 
findings that this relationship differs between plants (Conforti et al., 2008) and in 
some instances there is no relationship between the two. This is confirmed by the 
findings of Velioglu et al., (1998), who found a correlation between the two factors 
and Kahkonen et al., (1999) who found no correlation between polyphenolic content 
and antioxidant activity of the plants studied. Since phenolic compounds are the 
main contributors to the antioxidant properties of plants, it is believed that the quality 
A B 
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and quantity of the phenolic constituents are responsible for the difference in 
antioxidant activities (Shahidi and Marian, 2003). It is clear that water is a poor 
solvent for polyphenols, hence the lower value observed at a concentration similar to 
that of dichloromethane and methanol. This, however, does not discredit the use of 
aqueous extracts by traditional healers, as higher concentrations and volumes are 
usually used to obtain the desired effects. 
 
The LCMS analysis (Table 6.3) of the methanol A. ferox extract showed various 
peaks that were analysed, the elemental composition predicted and the molecular 
masses determined, to assist in the identification of the different compounds. The 
compounds were identified using three different online databases, namely KEGG, 
PubChem and ChemSpider. Aloesin, a chromone (Park et al., 2011) and promising 
anti-cancer agent as one of the most important phytochemicals found in aloes 
(Figure 6.2) was identified. Aloesin has apoptosis-stimulating activity and anti-
inflammatory activity (Park et al., 2011; Speranza et al., 2005).  As already 
mentioned in Chapter 1, anti-inflammatory agents are known to be used in cancer 
therapy since they ease the symptoms of cancer and improve the state of the 
patient. Different drugs and agents function in different mechanisms and the anti-
inflammatory action of the aloesin could be the cause of the positive reviews of A. 
ferox by local healers.  
 
The other identified compounds have not been studied for their therapeutic potential 
yet. However, retonone is a herbicide and pesticide that damages the mitochondria, 
hindering the respiratory chain (Vallin and Low, 1968; Valtierra, 2009). It has been 
shown to reduce adenosine triphosphate (ATP) synthesis in rats (Lu and Chang,  
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2009) and to cause retonone- induced neuronal cell death (Liu et al., 2012). The 
effects of these compounds can be studied further to investigate how they can be 
applied in disease control and treatment. It may be possible to apply their ability to 
disrupt cell life, whether through inhibited ATP production, cell death or in microbial 
treatment.   
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Table 6.3. Elemental composition predictions from LCMS spectra of the methanol extract of Aloe ferox. 
  
Mass 
Calculated 
mass 
 
Formula 
 
Final formula (M-
H)- 
 
Compound Name from (PubChem, ChemSpider and 
KEGG) databases 
1 393.1183 393.1186 C19H21O9 C19H22O9 Aloesin 
2  393.1127 C26H17O4 C26H18O4 5-methoxy-8-methyl-1,3-diphenyl-
benzo[f]isobenzofuran-4,9-quinone 
3  393.1244 C12H25O14 C12H25O14 Not found 
4  393.1279 C30H17O1 C30H18O 4H, 4H-4,4’-Bicyclopenta[def] phenanthren-4-ol. 
5  393.1033 C15H21O12 C15H22O12 propanoic acid [(2S)-2-hydroxy-2-[(2R)-5-hydroxy-3-
oxo-4-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-
(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-
furyl]ethyl] ester 
6  393.1338 C23H21O6 C23H22O6 Retonone 
7 181.0501 181.0501 C9H9O4 C9H10O4 Homovanillate or Homovanillic acid 
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    C19H22O9    
Exact mass: 394.1264                                                     
   Name: Aloesin                                            
 
Figure 6.2. Aloesin 
 
The GCMS analysis led to the identification of various (Figure 6.3) compounds via 
the computer library according to their retention indexes and masses. Each 
compound identified had a percentage probability above 20% (bold). These 
compounds are undecane (24.14), phosphoric acid trimethyl ether (81.23), p 
dioxane-2, 3 diol (21.37), butanedioc acid dimethyl ester (89.11/ 81.23/ 41.38), 
cyclotrisiloxane hexamethyl (33.27) and acetyl chloride (28.93). Most of the 
compounds have not been studied for their potential therapeutic activity as there is 
no evidence that they were previously isolated from A. ferox. 
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Figure 6.3. Gas chromatography mass spectrometry analysis of the methanol 
extract of A. ferox. 
 
6.5. Conclusions 
A. ferox is rich in compounds that are considered to be of major significance in the 
pharmaceutical industry. These compounds can serve as drug leads, part of drug 
combinations and sources of other derivatives. Compounds such as steroids, 
alkaloids, flavonoids and saponins, all of which are present in the extracts tested, are 
of major interest, as they form the starting point for the discovery and creation of new 
and improved drugs.  Polyphenols have a range of activities that function in the 
prevention and treatment of diseases, such as antioxidant activities and other 
enzymatic activities. Antioxidant activity is very important in the treatment and 
RT: 0.00 - 37.77
0 5 10 15 20 25 30 35
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
9.25
5.03
7.15
12.02
1.20 1.33
16.6215.95
20.8619.82 21.23 25.48 27.68 30.37 37.32
NL:
6.35E6
TIC F:   MS 
data01_14
051310143
4
81 
 
prevention of a wide range of diseases. The positive antioxidant activity of the A. 
ferox extract renders it very valuable therapeutically. 
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CHAPTER 7 
 
General discussion and conclusions 
 
7.1. Discussion 
Chapter 1 is an introduction to the world of medicinal plants and the current stand on 
natural sources for drugs. It also introduces A. ferox as a major contributor to local 
healthcare because of its phytochemical make up. Although it is most commonly 
known locally for its laxative properties, A. ferox Mill. has over 80 recorded medicinal 
uses. Some of these uses have been recorded in caves by the San people, showing 
just how far back recognition of the value of this plant goes (Grace, 2011; Reynolds, 
1950). The benefits of this plants are vast and include treatment for infertility (Grace 
et al., 2008), solar radiation protection (Grollier et al., 1987) and even treatment for 
microbial and inflammatory infections caused by viruses, bacteria or fungi. This plant 
has generated great interest and its use is rapidly growing into a multi-billion dollar 
business (International Aloe Science Council, 2004).  
 
The anti-cancer activity of A. ferox against selected cell lines (MCF7, HCT116 and 
PC3) was investigated using the SRB method (Chapter 2). According to the CSIR 
criteria, aqueous, methanol and dichloromethane A. ferox extracts were inactive 
against the three tested cancer cell lines, despite the fact that it contains aloe-
emodin, which has apoptosis-promoting properties (Chiu et al., 2009). One of the 
recorded uses of A. ferox is as an anti-tumour agent; it was therefore expected that 
the extracts would show some degree of antioxidant activity.  
 
Aloe species are widely known locally as treatment for STIs caused by bacteria, 
viruses, fungi and even parasitic infections. The glycoside compound found in the gel 
87 
 
and exudates of the plant leaves is credited with the ability to invade bacterial cells 
(Niciforovic et al., 2007). This may explain the positive results obtained when the 
extract was tested against a number of bacterial and fungal strains (Chapter 3). It 
was, however, inactive and unable to inhibit the growth of C. tropicalis and E. 
faecalis despite being able to inhibit E. coli, Staph. epidermidis, Strep. pneumonieae 
and C. albicans at the same concentration (15 mg/ml). It is possible that the extract 
showed inactivity at concentrations as high as 11 mg/ml owing to the fact that only 
crude extracts were used. The concentrations used were very high compared to 
those used by other researchers who obtained positive results for anti-bacterial and 
anti-fungal activity. Most of these researchers used fractionated compounds from the 
A. ferox leaf.    
 
A. ferox plant extracts were able to increase glucose uptake by C2C12 cells, which 
are muscle cells, after treatment with the extracts (Chapter 4). There was, however, 
an insignificant decrease in glucose uptake by Chang cells after treatment with the 
extracts. The aqueous extract of A. ferox gave displayed higher anti-diabetic activity 
than the methanol extracts, which validates the belief in and use of this plant by local 
healers to manage diabetes. They usually prescribe it as a way to treat symptoms 
resulting from diabetes complications. 
 
Since A. ferox is widely used locally to treat different ailments, sometimes with no 
prescriptions, it is important to determine whether the plant is in fact safe for human 
consumption and use. The safety of this plant against normal cells was investigated 
and the results are reported in Chapter 5. With two different methods used (MTT and 
SRB), the plant proved to be non-toxic to the selected cell lines (C2C12 and Chang 
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cells) in- vivo. The extracts also showed no cytotoxic activity against normal human 
foetal lung fibroblasts (W318). Thus it is safe to use, as it does not affect normal cells 
or cause any harm to them. In some instances the methanol extracts of A .ferox 
showed to be better than insulin and metformin as it cause less decrease to cell 
viability (MTT activity). These findings compound on the lack of any literature that 
reports A. ferox to have any toxic effects. 
 
A number of qualitative and quantitative assays were used to detect, isolate and 
identify the phytochemical makeup of A. ferox Mill. and the findings were reported in 
Chapter 6. Phytochemicals such as steroids, phenols, alkaloids, flavonoids and 
saponins were found in the methanol and aqueous extracts. These are some of the 
most valuable phytochemicals, as they can be the starting point for a wide range of 
drugs and chemical entities. LCMS and GCMS assays were able to isolate and 
identify the major compounds in the methanol extract of A. ferox. The main and well-
studied compound found was aloesin, a chromone with anti-inflammatory and 
apoptosis-inducing activity. It is part of compounds found in the gel of A. ferox and is 
responsible for most of the activity exhibited by the plant.  
 
According to the results obtained, a lot of value can be placed on A. ferox, as it 
displays therapeutic effects. Although it proved inactive against the selected cancer 
cell lines, this does not mean it has no anti-cancer or anti-tumour activity and does 
not discredit its use by local traditional healers as treatment for cancer. It might 
function through other mechanisms that improve and strengthen the immune system 
and general well-being of individuals, which goes a long way in fighting cancer and 
other diseases. A. ferox extracts tested proved to have a wide range of compounds 
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that explain the therapeutic activity of the plant. The antioxidant activity of the plant 
means that it displays an array of activities. Anti-oxidation is required for the 
prevention and treatment of a wide range of diseases, such as diabetes, cancer, 
inflammation, arthritis, cardiovascular disorders etc. These findings emphasise the 
importance of plants in human health.  Plants are able to supply the body with 
substances that it fails to obtain from the diet or that it lacks because of the lifestyle 
of individuals. Plants remain an untapped source of therapeutic agents and remedies 
that greatly improve and in some instances maintain human life. 
 
It is recommended that this plant be investigated in more detail, especially its anti-
cancer potential. More should be done, using purified compounds isolated from the 
extracts, as the crude extract may not show activity because of the low content of 
active compounds compared to inactive ones. The anti-diabetic activity of this plant 
should also be extensively studied and the mechanism of action determined. A. ferox 
may prove to be a good source of an alternative drug from metformin. As a natural 
source it may present fewer side effects compared to other therapies and drugs in 
use today. 
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INTROduCTION
There is a growing interest across the world for the discovery 
of new drugs, especially from natural sources such as plants. 
They present a less expensive and non-toxic option for health 
care. The increased use of plants worldwide can be credited 
to high unemployment rates, expensive healthcare and life in 
general[1,2]. The development of resistance to synthetic drugs by 
different organisms as well as the toxicity of these drugs also 
contributes to the major interest in plants as potential sources 
of different therapeutic drugs. Due to the alarming high rates of 
uncontrolled harvesting, some of the South African plant spe-
cies stay threatened and may become extinct. This can happen 
before their potential as useful sources of drugs can be discov-
ered[2].
Chronic diseases such as cancer, diabetes, cardiovascular and 
neurodegenerative diseases fuelled by the ways of life of the 
modern generation are affecting the entire world. Most of the 
common diseases except, bacterial and fungal diseases result 
from oxidative stress damage from reactive oxygen species 
(ROS) and reactive nitrogen species (RNS)[3,4]. These ROS and 
RNS entities can only be eradicated by antioxidant compounds 
found in high quantities in fruits, vegetables and other plants. 
The antioxidants present in plants can be used to replace the 
possibly carcinogenic and harmful synthetic antioxidants such 
as butylatedhydroxytoluene (BHT) and butylatedhydroxyanisole 
(BHA)[5,4]. Polyphenols which also have antimutagenic and an-
ticancer activity are the most commonly studied antioxidants[6].
It is due to this activity and their abundance in medicinal plants 
that ethnobotany has become the centre of focus for most re-
searchers.
The Asphodelaceae family has polyphenol- rich species. Only 
a few of these species have been investigated[7] and most of the 
scientific evaluation has only been done on Aloe vera which 
is highly used in cosmetics. Aloe vera has antiseptic, wound 
healing, antitumor and antidiabetic properties. Due to the di-
versity of the genus and their abundance in South Africa, the 
local communities have decided to use which ever species is 
available in their region[8]. 
Although plant species such as Aloe ferox Mill. are widely used 
and have many documented medicinal uses, their use, role as 
well as efficiency is still to be studied and validated. Aloe ferox 
is locally used for its antibacterial, antifungal as well as laxative 
properties[7]. The Aloe ferox leaf gel alone has been shown to 
contain polyphenols, indoles and alkaloids which all have anti-
oxidant capacity[8]. These findings make Aloe ferox a possible 
source of antitumor agents. In this study different extracts of the 
Aloe ferox leaf were screened for anticancer and antioxidant 
activities. The phytochemical screening and total polyphenol 
determination were also carried out on the extracts.
MATERIALS ANd METhOdS
Sample preparation
Aloe ferox was purchased from a nursery in Pretoria, South Af-
rica. A voucher specimen (RM001) was kept for future reference 
in the Biomedical Technology research laboratory at the Central 
University of Technology. The leaves were washed, oven dried 
at 40ºC, pulverized. Ten grams of the powdered plant material 
was then soaked separately in 150 ml of different solvents; puri-
fied water, methanol, and dichloromethane and shaken for 72 
hours, after which the extracts were filtered. The methanol and 
dichloromethane solvents were then removed through rotary 
evaporation at 35ºC and the water extracts were lyophilized. 
Before screening for different activities, the extracts were re- 
dissolved into the appropriate solvents in accordance to the 
required concentrations and volumes for each assay.
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Phytochemical screening
Different qualitative methods from De et al.[9] were used to 
determine the phytochemical make up of Aloe ferox extract. 
The extracts were screened for carbohydrates, proteins, steroids, 
saponins, alkaloids and flavonoids.
Test for carbohydrates: Fehling’s test
To 2 ml of the sample, 2 ml of Fehling’s reagent A and B were 
added. The solution was then shaken and boiled. The formation 
of a brick- red precipitate (cuprous oxide) indicates the pres-
ence of reducing sugars.
Test for steroids: Libermann- Buchard test
A few drops of acetic anhydride were added to treat the extract, 
the mixture boiled and then cooled. Sulphuric acid was added 
to the mixture drop by drop to the sides of the test tube. The 
presence of steroids was indicated by formation of a brown ring 
at the junction of the two layers with the upper layer turning 
green. Formation of a deep red colour at the upper layer indi-
cated the presence of triterpenoids.
Test for saponins: The foam test
Two millilitres of the extract were mixed with 2 ml of distilled 
water and the solution was shaken vigorously. The formation of 
persistent foam was an indication for the presence of saponins 
in the extract.
Test for alkaloids: Dragendorff’s test
The extract was mixed with a few ml of Dragendorff’s reagent. 
Alkaloids give a reddish brown precipitate.
Test for flavonoids: Shinoda’s test
Flavonoids give a pink scarlet, green or a green to blue colour 
after addition of a few fragments of magnesium ribbons and a 
drop-wise addition of concentrated hydrochloric acid.
Anticancer activity screening
The human cancer cell lines MCF7 (breast cancer) and PC3 
(prostate cancer) were obtained from the National Cancer In-
stitute (NCI) in the frame work of collaborative research pro-
gramme between Council for Scientific and Industrial Research 
(CSIR) and NCI in Pretoria, South Africa. The colon cancer cell 
line (HCT116) was obtained from European Collection of Cell 
Cultures (ECACC). The cell lines were maintained in a monol-
ayer cell culture at 37ºC, 5% CO2, 95% AIR and 100% relative 
humidity in RPMI containing 5% fetal bovine serum, 2mM L- 
glutamine and 5 µg/ml gentamicin.
The Sulforhodamine B (SRB) assay method by Monks and col-
legues[10] was used to test the cancer growth inhibitory effects 
of the Aloe ferox extracts against 3 cancer cell lines. The cells 
were inoculated on 96 well microtiter plates at plating densities 
of 7- 10 000 cells per well. They were then incubated at 37ºC 
for 24 hours after which one plate was fixed with TCA. This plate 
was labelled the (T0) and represented the measurement of cells 
inoculated in each plate before drug addition. The test extracts 
at different concentrations (6.25- 100µg/ml) were added to the 
other plates (Ti). The plates were then incubated for 48 h af-
ter which cold 50% trichloroacetic acid was used to fix viable 
cells to the bottom of each well. The cells were then washed, 
dried and dyed with SRB. Optical density measurements on a 
multiwell spectrophotometer were used to calculate the net cell 
growth percentage at 540nm. The following equations were 
used to calculate the percentage cell growth:
[(Ti- T0)/(C- T0)] x 100 for concentrations at which Ti≥ T0.
[(Ti- T0)/ T0] x 100 for concentrations at which Ti<T0.
The biological activities of the extracts were reported as Total 
Growth Inhibition (TGI) and divided into 4 categories as shown 
in Table 1. Cells without any drug/ extract added were used as 
the control, the blank was complete medium without any cells 
and the Etoposide was used as the standard.
Antioxidant activity screening
The method described by Brand- Williams[11] with some modifi-
cations was used to screen the plant extracts for antioxidant ac-
tivity. A stable radical 2, 2- dipheny- 1- picrylhydrazyl (DPPH) 
at 0.1mM was used to investigate the free radical scavenging 
activity of the extracts. Ascorbic acid, an antioxidant was used 
as a standard. One hundred millilitres of methanolic solutions 
of the extract at various concentrations (0.078-2.5 mg/ml) was 
added to 2 ml of the DPPH solution. The mixtures were shaken 
vigorously and then incubated in the dark at room temperature 
for 1 hour. The absorbance of the solution was then measured 
with a Helios Epsilon, CAT: 9423UVE1000E ThermoSpectronic 
spectrometer at 517nm, and the percentage of antioxidant ac-
tivity (AA) calculated using the following formula:
AA% = 100-{[(Abssample–Absblank) x 100]/Abscontrol}
A solution of methanol (0.1 ml) and DPPH (2 ml) was used as 
the control and for the blank, methanol (1ml) was used. The 
EC50 for the sample was determined from a plotted graph of 
DPPH disappearance as a function of sample concentration.
Total phenolic content
The total phenolic content of the plant extracts was determined 
using the Folin- Ciocalteu method according to Waterhouse[12] 
with a few modifications. Gallic acid which is a strong anti-
oxidant was used as the standard from which the phenolic 
concentration of the sample was determined and expressed 
as mg gallic acid equivalent (GAE). The sample (0.1 ml) was 
mixed with 46ml of distilled water in 50 ml volumetric flask 
and 1ml of 2N Folin- Ciocalteu reagent added. The mixture 
was then thoroughly mixed and allowed to react for 3 minutes 
after which it was topped up to 50 ml with sodium carbon-
ate solution (2%). Then the solutions were allowed to incubate 
for 2 hours at room temperature, after which the absorbance 
of the solutions was measured at 760nm with the Helios Ep-
silon, CAT: 9423UVE1000E ThermoSpectronic spectrometer. 
This procedure was also followed for gallic acid to obtain the 
standard curve.
RESuLTS ANd dISCuSSION
Phytochemical screening 
The aqueous plant extract showed no presence of proteins but 
was positive for carbohydrates, saponins, steroids, alkaloids 
as well as flavonoids. The presence of steroids and alkaloids 
strongly suggest that these extracts may have a potential in the 
production of anti- inflammatory or even anticancer agents. 
Any agent that has steroids and alkaloids is a strong contender 
Table 1: Categories of anticancer activity (CSIR criteria).
TGI Category
>50 µg/ml Inactive
<50 µg/ml > 15 µg/ml Weak activity
<15 µg/ml > 6.25 µg/ml Moderate activity
<6.25 µg/ml Potent activity
38  www.smltsa.org.za  |  ISSN 1011 5528
Volume 27 No. 2  |  December 2013Medical Technology SA
Table 2: The biological activities of the extracts against the MCF7, HCT116 and PC3 cancer cell lines.
Etoposide Methanol extract dichloromethane extract
Activities MCF7 hCT116 PC3 MCF7 hCT116 PC3 MCF7 hCT116 PC3
GI50 <6.25 19.96 34.64 86.56 >100 >100 86.72 >100 46.09
TGI >100 >100 >100 >100 >100 >100 >100 >100 >100
LC50 >100 >100 >100 >100 >100 >100 >100 >100 >100
LC100 >100 >100 >100 >100 >100 >100 >100 >100 >100
Figure 1: Effect of Methanol and dichloromethane extracts of Aloe ferox against the breast cancer (MCF7), colon cancer (HCT116) and prostate cancer (PC3) cell lines.
Figure 2: Free radical scavenging activity of the methanolic A. ferox extract.
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in the fight against cancer and other chronic inflammatory 
diseases as majority of these compounds have been found to 
have anti- inflammatory, free radical scavenging and apoptosis 
inducing properties[13]. The presence of saponins may also fur-
ther indicate the presence of steroids and triterpenoids which 
often present in the form of saponins[14]. The pharmacological 
effects of plants are a result of the activity of single compounds 
or a synergetic effect of the compounds[15]. The presence of fla-
vonoids also contributes to the antioxidant activity of the plant 
extracts as in addition to free radical scavenging; they also have 
vein strengthening effects[16]. They have anti- inflammatory, anti- 
allergic, antibacterial and antiviral effects[17]. The results of the 
present study show compounds that may support the findings 
by Kambizi[18].
Anticancer activity screening
According to the CSIR criteria (Table 1), the tested extracts 
(methanol and dichloromethane) are inactive against all the 
cell lines as indicated in Figures 1. The methanol extract ex-
hibited inactivity against the colon, breast and the prostate 
cancer cell lines with the TGI of more than 100 µg/ml for all of 
them. Table 2 shows the results of all the parameters measured. 
As shown the extract did show a lower GI50 of 86.56 µg/ml 
against the breast cancer cell line. The dichloromethane extract 
also showed no activity against the three cell lines with a TGI 
of more than 100 µg/ml. However the extract showed a 50% 
inhibitory concentration of 46.09 µg/ml against the prostate 
cancer cell line which is much lower compared to the 86.72 µg/
ml needed to exert the same activity against the breast cancer 
cell line. The inactivity of the extracts is not discouraging as the 
etoposide was also inactive against the cell lines as shown on 
Figure 1. It required a concentration of more than 6.25 µg/ml to 
have GI50 against the prostate and colon cancer cell lines. The 
inactivity of the extracts against these certain cell lines does not 
mean the plant has no anti- cancer activity as more evaluation 
against other cancer cell lines needs to be done. The inactivity 
may also mean the concentrations used were low for both the 
etoposide and the test extract.
Antioxidant activity
The DPPH radical scavenging activity of the methanolic extract 
is shown in Table 3. The methanolic extract was able to reduce 
the stable free radical DPPH to a yellow coloured 1,1- diphenyl-
2-picrylhydarzyl and this activity was thought to be a result of 
the hydrogen- donating ability of the extract compounds. The 
extracts have potent antioxidant activity which was compared 
to that of the standard (ascorbic acid), shown in Figure 2. The 
highest activity (101 ± 0.042%) was achieved at extract concen-
tration of 2.5 mg/ml. The EC50 of the extract was 0.865 mg/ml 
compared to that of ascorbic acid which was 0.042 mg/ml.
Total phenolic content
Table 4 reports the results of total phenolics of the different ex-
tracts. The extracts were analysed at 5mg/ml against gallic acid. 
The phenolic content varied between the extracts. Methanol 
extracted more polyphenols than water or dichloromethane. 
The gallic acid equivalents of the estimated phenolic concentra-
tions are arranged in ascending order in Table 4 and range from 
0.340 ± 0.057 to 0.726 ± 0.032 mg/ml GAE.
CONCLuSION
In conclusion, the results of this study show that A. ferox has 
antioxidant capabilities which may be due to its polyphenolic 
composition. Methanol extracts more polyphenols than water 
and dichloromethane. The presence of alkaloids, steroids and 
flavonoids as proved by the phytochemical screening show that 
this plant has the potential to prevent development of symptoms 
of cardiovascular diseases, diabetes, cancer and other inflam-
matory diseases. They are the main constituents of most of the 
drugs currently in use for these diseases. Further testing espe-
cially using different cell lines for anticancer screening should 
be done to validate the plant’s use for cancer treatment. The lack 
of activity against cancer cells could also mean that the plant 
functions against cancer through other mechanisms that do 
not affect the cancer cells directly. Some of these mechanisms 
could be by easing pain, inflammation and other symptoms.
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